<DOC>
	<DOC>NCT00800241</DOC>
	<brief_summary>The purpose of this study is to determine the incidence of misuse, i.e., over-use and under-use, of Budesonide/formoterol for maintenance and reliever therapy in usual-care setting.</brief_summary>
	<brief_title>Budesonide/Formoterol for Maintenance and Reliever Therapy Among Asthma Patients in Thailand</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Established persistent asthma Currently treated with Symbicort SMART for 3 months or longer currently participating or have participated in a study with an investigational compound within the last 30 days current diagnosis of chronic obstructive pulmonary disease (COPD) smoked more than 10 packyear</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Symbicort SMART</keyword>
	<keyword>Thai patient eligibility</keyword>
	<keyword>Persistent asthma</keyword>
</DOC>